Frederick Gluck


Mr. Gluck retired in 1995 from McKinsey & Company, Inc., the international management consulting firm, after serving for six years as its Managing Director. At McKinsey, Mr. Gluck consulted extensively with U.S., European and Far East companies, with particular emphasis in the telecommunications, electronics, heavy-machinery and healthcare industries. Under his leadership, McKinsey doubled in size and greatly expanded its international presence, particularly in Asia and Latin America. After leaving McKinsey, Mr. Gluck joined the Bechtel Group as Vice Chairman and Director, retiring from there in 1998. Since retiring from Bechtel, Mr. Gluck founded CytomX – a biotech therapeutics company that listed on NASDAQ in October as CTMX.